메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: Drug hypersensitivity is difficult to predict, although it commonly occurs in medical practice. It can be prevented by avoidance of re-administration of causative drugs through a complete search for individual history of drug allergy. Objective: To investigate the epidemiological feature of drug hypersensitivity reported to the order communication system (OCS) and to evaluate the efficacy of a preventive program. Method: We developed computer-based surveillance system for drug hypersensitivity, ie. drug allergy and idiosyncrasy. Informations on the occurrence and patient’s history of drug hypersensitivity reactions, including symptoms, signs and the presumably causative drugs were inputted into OCS by doctors and nurses at Asan Medical Center from April through July of 2003. These informations were transferred to allergy specialists, and after their review, were automaticallynoticed on every prescribing process for the patients in the OCS. Result: Previous history of drug hypersensitivity was reported in 0.23% (48/20,525) of inpatients and 3.22% (61/ 1,892) of Allergy Clinic outpatients. The occurrence of drug hypersensitivity reactions was reported in 54 patients during the 4 months of monitoring thus the estimated incidence was 789/100,000 inpatients per year. Among them, past medical histories of drug hypersensitivity to the same causative drugs were identified retrospectively in 8 patients. Major causative drugs were antibiotics and radiocontrast dyes. Conclusion: For preventing the recurrence of drug hypersensitivity reaction, it is necessary to develop a mandatory computer program to register the patient’s history of drug hypersensitivity in the OCS.

목차

등록된 정보가 없습니다.

참고문헌 (9)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0